Compounds > 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Syndrome

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Syndrome in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asenbaum, S; Kovacs, GG; Perju-Dumbrava, L; Pirker, S; Pirker, W; Traub-Weidinger, T1
Dresel, S; Horak, M; Rüther, T; Soyka, M; Tatsch, K1
Camardese, G; Carli, V; Cuomo, C; De Risio, S; De Rossi, G; Di Giuda, D; Sarchiapone, M; Satta, MA1
Danek, A; Tatsch, K; Uttner, I; Vogl, T; Witt, TN1
Cordes, M; Felix, R; Harisch, C; Hierholzer, J; Hosten, N; Keske, U; Mäurer, J; Poewe, W; Richter, W; Schelosky, L; Venz, S1

Other Studies

5 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Syndrome

ArticleYear
Dopamine D2 receptor SPECT in corticobasal syndrome and autopsy-confirmed corticobasal degeneration.
    Parkinsonism & related disorders, 2013, Volume: 19, Issue:2

    Topics: Aged; Autopsy; Basal Ganglia Diseases; Benzamides; Dopamine Antagonists; Female; Humans; Male; Middle Aged; Neurodegenerative Diseases; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Retrospective Studies; Syndrome; Tomography, Emission-Computed, Single-Photon

2013
PET and SPECT findings in alcohol hallucinosis: case report and super-brief review of the pathophysiology of this syndrome.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2000, Volume: 1, Issue:4

    Topics: Alcoholism; Benzamides; Brain; Fluorodeoxyglucose F18; Hallucinations; Humans; Iodine Radioisotopes; Male; Middle Aged; Pyrrolidines; Radiopharmaceuticals; Serotonin; Syndrome; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon

2000
A case of Cotard syndrome: (123)I-IBZM SPECT imaging of striatal D(2) receptor binding.
    Psychiatry research, 2004, Jan-15, Volume: 130, Issue:1

    Topics: Adolescent; Adult; Benzamides; Binding, Competitive; Contrast Media; Corpus Striatum; Delusions; Humans; Male; Pyrrolidines; Receptors, Dopamine D2; Syndrome; Tomography, Emission-Computed, Single-Photon

2004
Cerebral involvement in McLeod syndrome.
    Neurology, 1994, Volume: 44, Issue:1

    Topics: Benzamides; Brain; Contrast Media; Genetic Linkage; Humans; Kell Blood-Group System; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Pyrrolidines; Syndrome; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; X Chromosome

1994
Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998, Volume: 39, Issue:6

    Topics: Adult; Aged; Benzamides; Binding Sites; Contrast Media; Corpus Striatum; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Observer Variation; Olivopontocerebellar Atrophies; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Reproducibility of Results; Supranuclear Palsy, Progressive; Syndrome; Time Factors; Tomography, Emission-Computed, Single-Photon

1998